# RISE THERAPEUTICS, LLC: Clinical Validation of a Synthetic Biology-Based Microbial Medicine to Treat Immunotherapy Refractory Solid Tumors

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | RISE THERAPEUTICS, LLC |
| Location | Rockville, MD |
| Project | Clinical Validation of a Synthetic Biology-Based Microbial Medicine to Treat Immunotherapy Refractory Solid Tumors |
| Project number | 1R44CA306440-01A1 |
| Mechanism | R44 |
| Institute | National Cancer Institute |
| Award | $740,140 |
| Awarded | 2026-09-16 |
| Project period | 2026-09-16 to 2029-08-31 |
| UEI | N36JMJ1DKWH6 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11399439). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.